Microarray analysis of bone marrow-derived macrophage cells treated with Kdo₂-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios KEGG pathway: Cell cycle (mmu04110) Legend: : View data/graphs for replicates Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr Abl1 KLA  ATP  ATP+KLA AK083248 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630031E05 product:v-abl Abelson murine leukemia oncogene 1, full insert sequence. [AK083248] KLA 1.07 1.07 .92 1.01 .98 1.07 .98 ATP .98 .99 .94 .90 .99 1.07 1.04 KLA/ATP 1.04 1.01 1.03 .98 .97 .95 .99 Abl1 KLA  ATP  ATP+KLA NM_009594 c-abl oncogene 1, receptor tyrosine kinase (Abl1), transcript variant 2, mRNA [NM_009594] KLA .63 .62 .65 .71 .96 1.17 1.05 ATP 1.01 1.16 1.03 1.14 1.12 .98 .98 KLA/ATP .66 .64 .67 .73 .84 .90 1.05 Anapc1 KLA  ATP  ATP+KLA AK090134 nullipotent stem cell CRL-2070 NE cDNA, RIKEN full-length enriched library, clone:G431003J08 product:meiotic check point regulator, full insert sequence [AK090134] KLA .79 .76 .72 .64 .56 .54 .76 ATP .99 1.04 1.11 .77 .48 .31 .39 KLA/ATP .72 .75 .73 .57 .42 .30 .25 Anapc1 KLA  ATP  ATP+KLA NM_008569 anaphase promoting complex subunit 1 (Anapc1), mRNA [NM_008569] KLA 1.00 .89 .81 .89 .66 .75 .74 ATP .88 .79 .97 .46 .48 .93 .76 KLA/ATP .76 .77 .83 .37 .44 .74 .62 Anapc10 KLA  ATP  ATP+KLA NM_026904 anaphase promoting complex subunit 10 (Anapc10), mRNA [NM_026904] KLA 1.38 1.24 1.22 1.30 1.13 1.14 1.05 ATP .96 .99 1.22 1.01 .77 1.16 .94 KLA/ATP 1.19 1.24 1.50 1.23 .97 1.17 1.02 Anapc11 KLA  ATP  ATP+KLA NM_001038230 anaphase promoting complex subunit 11 homolog (yeast) (Anapc11), transcript variant 1, mRNA [NM_001038230] KLA .89 .90 .91 .85 .82 .78 .82 ATP 1.01 1.06 1.04 1.06 1.00 .85 .75 KLA/ATP .96 .93 .83 .96 .87 .79 .64 Anapc13 KLA  ATP  ATP+KLA NM_181394 anaphase promoting complex subunit 13 (Anapc13), mRNA [NM_181394] KLA .98 .96 .89 .99 .85 .91 .72 ATP .99 .95 1.22 1.25 1.23 1.07 .67 KLA/ATP .95 1.01 1.27 1.23 1.35 1.19 .76 Anapc2 KLA  ATP  ATP+KLA NM_175300 anaphase promoting complex subunit 2 (Anapc2), mRNA [NM_175300] KLA .90 .92 1.02 .91 1.03 .94 .81 ATP 1.08 1.16 .96 1.18 .86 .75 .94 KLA/ATP 1.04 1.07 .93 1.11 .84 .66 .89 Anapc4 KLA  ATP  ATP+KLA NM_024213 anaphase promoting complex subunit 4 (Anapc4), mRNA [NM_024213] KLA .94 .99 1.01 1.08 1.21 1.22 1.09 ATP .95 .91 .86 .69 .61 .89 .96 KLA/ATP .93 .95 .84 .77 .80 .96 1.00 Anapc5 KLA  ATP  ATP+KLA NM_021505 anaphase-promoting complex subunit 5 (Anapc5), transcript variant 1, mRNA [NM_021505] KLA .80 .82 .83 .82 .79 .84 1.10 ATP .99 .99 .89 .81 .79 .70 .71 KLA/ATP .82 .81 .72 .62 .63 .73 .68 Anapc7 KLA  ATP  ATP+KLA AK049968 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630034H22 product:anaphase-promoting complex subunit 7, full insert sequence. [AK049968] KLA .89 .86 .88 .85 .91 .95 .89 ATP .92 .89 .89 .86 .96 .99 1.00 KLA/ATP .89 .79 .83 .85 .93 .92 .87 Anapc7 KLA  ATP  ATP+KLA NM_019805 anaphase promoting complex subunit 7 (Anapc7), mRNA [NM_019805] KLA .65 .69 .70 .79 .91 1.00 .92 ATP .96 .99 .81 .89 1.46 1.30 1.00 KLA/ATP .70 .73 .64 .72 1.14 1.28 1.04 Atm KLA  ATP  ATP+KLA NM_007499 ataxia telangiectasia mutated homolog (human) (Atm), mRNA [NM_007499] KLA 1.86 1.97 2.17 1.67 1.20 .86 .79 ATP 1.09 1.17 1.01 .97 .61 .63 .69 KLA/ATP 2.11 2.24 1.55 1.46 .85 .75 .59 BB217526 KLA  ATP  ATP+KLA AK083592 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030051F04 product:unclassifiable, full insert sequence [AK083592] KLA 1.53 1.19 1.21 1.15 1.61 1.14 .87 ATP 1.33 1.11 1.15 1.11 2.06 1.48 1.13 KLA/ATP 1.36 1.18 1.61 1.37 1.77 1.10 1.13 BI646741 KLA  ATP  ATP+KLA BI646741 gb|BI646741 603279769F1 NCI_CGAP_Mam3 Mus musculus cDNA clone IMAGE:5320025 5, mRNA sequence [BI646741] KLA .55 .54 .47 .54 .65 1.09 1.60 ATP 1.04 .99 .93 1.08 2.49 .79 .88 KLA/ATP .54 .49 .54 .60 1.21 .97 1.54 Bub1 KLA  ATP  ATP+KLA NM_009772 budding uninhibited by benzimidazoles 1 homolog (S. cerevisiae) (Bub1), transcript variant 2, mRNA [NM_009772] KLA .49 .43 .34 .28 .12 .12 .11 ATP 1.11 1.16 1.30 1.36 .79 .36 .09 KLA/ATP .49 .40 .42 .41 .24 .14 .07 Bub1b KLA  ATP  ATP+KLA NM_009773 budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae) (Bub1b), mRNA [NM_009773] KLA .31 .30 .30 .27 .23 .22 .13 ATP 1.10 1.06 1.02 .98 .60 .40 .15 KLA/ATP .35 .30 .32 .41 .32 .25 .15 Bub3 KLA  ATP  ATP+KLA AK083742 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030073O17 product:unclassifiable, full insert sequence. [AK083742] KLA .77 .74 .83 .76 .91 .80 .78 ATP 1.02 .74 .70 .69 1.08 1.05 .79 KLA/ATP .65 .65 .70 .72 1.02 .88 .64 Bub3 KLA  ATP  ATP+KLA NM_009774 budding uninhibited by benzimidazoles 3 homolog (S. cerevisiae) (Bub3), mRNA [NM_009774] KLA .84 .90 .90 .84 .86 .82 .76 ATP 1.07 1.10 1.04 1.14 .89 .84 .65 KLA/ATP .93 .97 .83 1.00 .80 .78 .48 Ccna1 KLA  ATP  ATP+KLA NM_007628 cyclin A1 (Ccna1), mRNA [NM_007628] KLA .97 .96 1.03 1.01 .97 .96 1.02 ATP .98 .99 1.00 1.01 .98 .95 .98 KLA/ATP 1.05 .96 1.01 1.04 .97 .92 1.01 Ccna2 KLA  ATP  ATP+KLA NM_009828 cyclin A2 (Ccna2), mRNA [NM_009828] KLA .28 .21 .19 .14 .09 .07 .06 ATP 1.17 1.11 1.03 1.01 .59 .20 .05 KLA/ATP .29 .22 .23 .21 .13 .08 .06 Ccnb1 KLA  ATP  ATP+KLA NM_172301 cyclin B1 (Ccnb1), mRNA [NM_172301] KLA .41 .37 .34 .29 .20 .18 .12 ATP 1.05 1.04 1.22 1.33 1.02 .54 .10 KLA/ATP .44 .37 .42 .39 .37 .22 .10 Ccnb2 KLA  ATP  ATP+KLA NM_007630 cyclin B2 (Ccnb2), mRNA [NM_007630] KLA .60 .51 .52 .39 .25 .15 .09 ATP .99 .89 1.32 1.14 .93 .55 .10 KLA/ATP .58 .52 .70 .59 .86 .47 .15 Ccnb3 KLA  ATP  ATP+KLA NM_183015 cyclin B3 (Ccnb3), mRNA [NM_183015] KLA 1.00 1.04 1.09 .93 1.03 1.05 1.03 ATP 1.00 1.02 .97 1.06 1.06 1.01 1.05 KLA/ATP 1.03 .99 1.04 1.04 1.10 1.12 1.03 Ccnd1 KLA  ATP  ATP+KLA S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17 ATP 1.02 1.02 .88 .80 .52 .10 .21 KLA/ATP .27 .23 .22 .24 .27 .25 .14 Ccnd2 KLA  ATP  ATP+KLA NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53 ATP .98 .75 .50 .57 1.24 2.83 .40 KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57 Ccnd3 KLA  ATP  ATP+KLA NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45 ATP 1.05 1.14 .89 1.20 .74 .76 .99 KLA/ATP .70 .67 .54 .83 .61 1.19 1.45 Ccne1 KLA  ATP  ATP+KLA NM_007633 cyclin E1 (Ccne1), mRNA [NM_007633] KLA 1.13 1.14 1.13 .78 .51 .69 .55 ATP .92 .94 1.09 .93 .75 .71 .47 KLA/ATP 1.13 1.17 1.45 1.24 1.33 1.50 .85 Ccne2 KLA  ATP  ATP+KLA NM_001037134 cyclin E2 (Ccne2), transcript variant 1, mRNA [NM_001037134] KLA .34 .35 .42 .36 .35 .36 .26 ATP 1.02 1.11 1.01 .82 .58 .38 .23 KLA/ATP .36 .34 .44 .43 .41 .40 .25 Ccnh KLA  ATP  ATP+KLA NM_023243 cyclin H (Ccnh), mRNA [NM_023243] KLA .68 .70 .59 .60 .51 .67 .86 ATP .95 .98 1.23 1.05 .60 .37 .85 KLA/ATP .65 .63 .70 .61 .44 .33 .44 Cdc14a KLA  ATP  ATP+KLA AK048250 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130043F22 product:similar to CDC14A3 PHOSPHATASE [Homo sapiens], full insert sequence. [AK048250] KLA .93 .89 .93 .90 1.01 .99 .92 ATP 1.00 1.07 .96 .94 1.08 .99 .93 KLA/ATP 1.00 .96 .95 .90 .93 .86 .89 Cdc14a KLA  ATP  ATP+KLA NM_001080818 CDC14 cell division cycle 14 homolog A (S. cerevisiae) (Cdc14a), mRNA [NM_001080818] KLA 1.62 1.46 1.26 1.03 1.19 1.08 1.04 ATP .97 .95 1.14 .86 1.14 1.27 .85 KLA/ATP 1.55 1.54 1.50 1.06 .97 1.02 .78 Cdc14b KLA  ATP  ATP+KLA NM_172587 CDC14 cell division cycle 14 homolog B (S. cerevisiae) (Cdc14b), transcript variant 1, mRNA [NM_172587] KLA .63 .62 .58 .63 .67 .75 .82 ATP 1.01 1.01 .88 .70 .79 .72 .93 KLA/ATP .65 .60 .59 .54 .83 .72 .65 Cdc16 KLA  ATP  ATP+KLA AK012511 11 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2700071J12 product:unclassifiable, full insert sequence. [AK012511] KLA .97 .92 .89 .90 .93 .92 .99 ATP .97 .94 .89 .92 .89 .94 .91 KLA/ATP .98 .88 .99 .93 .80 .89 .82 Cdc16 KLA  ATP  ATP+KLA NM_027276 CDC16 cell division cycle 16 homolog (S. cerevisiae) (Cdc16), mRNA [NM_027276] KLA .96 .98 .97 .90 .89 .85 .88 ATP 1.03 1.02 1.06 .82 .70 .87 .71 KLA/ATP .96 .93 .96 .79 .68 .73 .61 Cdc20 KLA  ATP  ATP+KLA NM_023223 cell division cycle 20 homolog (S. cerevisiae) (Cdc20), mRNA [NM_023223] KLA .18 .15 .14 .12 .10 .09 .06 ATP .91 .88 1.33 1.11 .72 .46 .07 KLA/ATP .16 .15 .20 .18 .19 .17 .07 Cdc23 KLA  ATP  ATP+KLA NM_178347 CDC23 (cell division cycle 23, yeast, homolog) (Cdc23), mRNA [NM_178347] KLA .74 .76 .75 .74 .72 .79 .79 ATP 1.06 1.04 .91 .71 .48 .60 .71 KLA/ATP .76 .77 .73 .66 .46 .51 .59 Cdc25a KLA  ATP  ATP+KLA NM_007658 cell division cycle 25 homolog A (S. pombe) (Cdc25a), mRNA [NM_007658] KLA .76 .77 .75 .68 .83 1.00 .95 ATP .97 1.03 .83 .69 1.01 .84 .79 KLA/ATP .69 .71 .80 .70 .91 .81 .81 Cdc25a KLA  ATP  ATP+KLA U27323 Cdc25a (cdc25a) mRNA, complete cds. [U27323] KLA .62 .60 .58 .58 .77 .87 .87 ATP 1.16 1.04 .77 .57 1.16 .74 .72 KLA/ATP .65 .64 .63 .54 .86 .68 .58 Cdc25b KLA  ATP  ATP+KLA NM_023117 cell division cycle 25 homolog B (S. pombe) (Cdc25b), transcript variant 1, mRNA [NM_023117] KLA .38 .34 .33 .34 .30 .31 .26 ATP .98 1.04 1.01 .89 .67 .58 .39 KLA/ATP .36 .33 .37 .40 .51 .43 .32 Cdc25c KLA  ATP  ATP+KLA NM_009860 cell division cycle 25 homolog C (S. pombe) (Cdc25c), mRNA [NM_009860] KLA .62 .63 .62 .61 .50 .49 .29 ATP .95 1.00 .97 .97 .73 .64 .28 KLA/ATP .61 .62 .61 .68 .67 .64 .32 Cdc26 KLA  ATP  ATP+KLA AK041840 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630041F01 product:unclassifiable, full insert sequence. [AK041840] KLA .92 .88 .95 .88 1.08 .99 1.15 ATP .72 .64 .61 .75 .91 .85 1.04 KLA/ATP .84 .75 .66 .87 .94 .95 .99 Cdc26 KLA  ATP  ATP+KLA NM_139291 cell division cycle 26 (Cdc26), mRNA [NM_139291] KLA 1.04 1.07 1.01 1.25 1.38 1.55 1.25 ATP .98 .97 1.06 .91 .91 1.47 1.38 KLA/ATP .88 1.02 1.24 .99 1.25 1.66 1.74 Cdc27 KLA  ATP  ATP+KLA NM_145436 cell division cycle 27 homolog (S. cerevisiae) (Cdc27), mRNA [NM_145436] KLA 1.36 1.25 1.22 1.07 1.05 1.06 1.00 ATP .90 .97 1.06 .84 .81 .88 .73 KLA/ATP 1.25 1.22 1.07 .87 .98 .95 .72 Cdc2a KLA  ATP  ATP+KLA NM_007659 cell division cycle 2 homolog A (S. pombe) (Cdc2a), mRNA [NM_007659] KLA .72 .68 .65 .58 .58 .59 .48 ATP 1.01 1.05 1.21 1.06 .83 .77 .51 KLA/ATP .68 .63 .79 .70 .59 .59 .51 Cdc45l KLA  ATP  ATP+KLA NM_009862 cell division cycle 45 homolog (S. cerevisiae)-like (Cdc45l), mRNA [NM_009862] KLA .37 .37 .33 .38 .33 .40 .31 ATP 1.08 1.15 1.07 1.30 .66 .43 .32 KLA/ATP .46 .37 .51 .46 .35 .37 .24 Cdc6 KLA  ATP  ATP+KLA NM_011799 cell division cycle 6 homolog (S. cerevisiae) (Cdc6), transcript variant 1, mRNA [NM_011799] KLA .31 .32 .37 .37 .41 .49 .33 ATP 1.01 .92 1.03 .74 .66 .44 .32 KLA/ATP .31 .32 .47 .50 .75 .53 .28 Cdc7 KLA  ATP  ATP+KLA NM_009863 cell division cycle 7 (S. cerevisiae) (Cdc7), mRNA [NM_009863] KLA .54 .53 .57 .59 .57 .57 .57 ATP 1.01 1.05 .95 .77 .75 .61 .62 KLA/ATP .51 .54 .65 .60 .65 .64 .52 Cdk2 KLA  ATP  ATP+KLA NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73 ATP 1.02 1.14 .91 .92 .68 .71 .65 KLA/ATP .67 .64 .64 .64 .61 .74 .62 Cdk4 KLA  ATP  ATP+KLA NM_009870 cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] KLA .66 .72 .65 .55 .46 .50 .71 ATP 1.03 1.02 .53 .65 .66 .63 .75 KLA/ATP .78 .61 .31 .42 .44 .62 .43 Cdk6 KLA  ATP  ATP+KLA AK030810 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830411I20 product:unclassifiable, full insert sequence [AK030810] KLA 1.05 .96 .67 .51 .48 .49 .45 ATP 1.02 .91 .78 .49 .50 .47 .44 KLA/ATP 1.01 .89 .65 .40 .36 .26 .49 Cdk6 KLA  ATP  ATP+KLA NM_009873 cyclin-dependent kinase 6 (Cdk6), mRNA [NM_009873] KLA 2.63 2.36 2.14 1.80 1.55 1.32 1.03 ATP 1.11 1.21 1.06 1.23 .94 1.30 2.08 KLA/ATP 2.58 2.69 2.24 2.25 1.38 .85 3.00 Cdk7 KLA  ATP  ATP+KLA NM_009874 cyclin-dependent kinase 7 (homolog of Xenopus MO15 cdk-activating kinase) (Cdk7), mRNA [NM_009874] KLA 1.18 1.15 1.15 1.13 1.08 1.01 1.19 ATP 1.01 1.06 .92 .72 1.06 1.79 1.12 KLA/ATP 1.11 1.23 1.45 .81 .88 1.24 .93 Cdkn1a KLA  ATP  ATP+KLA NM_007669 cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a), transcript variant 1, mRNA [NM_007669] KLA 4.72 4.90 4.96 3.73 2.11 1.14 1.02 ATP 1.14 1.52 .95 1.69 1.47 2.21 .50 KLA/ATP 5.99 7.08 3.86 6.37 3.00 2.55 2.05 Cdkn1b KLA  ATP  ATP+KLA NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97 ATP .99 1.09 .97 1.06 1.48 .94 .91 KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09 Cdkn1c KLA  ATP  ATP+KLA NM_009876 cyclin-dependent kinase inhibitor 1C (P57) (Cdkn1c), mRNA [NM_009876] KLA .92 .88 .90 .86 .74 .48 .26 ATP 1.02 .94 1.30 3.66 4.13 3.37 2.11 KLA/ATP .97 .93 1.29 3.88 5.15 3.03 1.63 Cdkn2a KLA  ATP  ATP+KLA NM_009877 cyclin-dependent kinase inhibitor 2A (Cdkn2a), transcript variant 1, mRNA [NM_009877] KLA .95 .95 .86 .96 .91 .90 .75 ATP 1.00 .99 .95 .95 .97 .89 .77 KLA/ATP .95 .96 .92 .94 .90 .85 .76 Cdkn2b KLA  ATP  ATP+KLA NM_007670 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (Cdkn2b), mRNA [NM_007670] KLA .70 .75 .94 1.44 1.66 .55 .81 ATP 1.02 .89 1.00 .86 1.33 3.87 .57 KLA/ATP .71 .77 .91 .94 .74 1.64 1.17 Cdkn2c KLA  ATP  ATP+KLA NM_007671 cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (Cdkn2c), mRNA [NM_007671] KLA .32 .29 .29 .27 .20 .20 .15 ATP .88 .87 .62 .52 .49 .39 .23 KLA/ATP .30 .29 .30 .34 .34 .34 .20 Cdkn2c KLA  ATP  ATP+KLA U19596 Cdk4 and Cdk6 inhibitor p18 protein mRNA, complete cds. [U19596] KLA .32 .32 .30 .27 .21 .20 .15 ATP .91 .90 .57 .52 .49 .40 .22 KLA/ATP .35 .31 .29 .36 .35 .35 .20 Cdkn2d KLA  ATP  ATP+KLA NM_009878 cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) (Cdkn2d), mRNA [NM_009878] KLA 1.71 1.79 2.80 5.07 4.61 2.23 .68 ATP .92 .80 .79 .80 .82 1.86 .87 KLA/ATP 1.62 1.54 2.45 2.18 4.35 3.47 1.84 Chek1 KLA  ATP  ATP+KLA NM_007691 checkpoint kinase 1 homolog (S. pombe) (Chek1), mRNA [NM_007691] KLA .36 .35 .37 .36 .34 .44 .31 ATP 1.12 1.14 1.17 1.08 .64 .43 .32 KLA/ATP .37 .36 .48 .46 .49 .36 .25 Chek2 KLA  ATP  ATP+KLA NM_016681 CHK2 checkpoint homolog (S. pombe) (Chek2), mRNA [NM_016681] KLA .55 .54 .46 .55 .47 .52 .59 ATP 1.07 1.10 .83 .88 .64 .61 .62 KLA/ATP .54 .51 .49 .55 .56 .57 .46 Crebbp KLA  ATP  ATP+KLA AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24 ATP .98 .90 1.04 1.11 1.95 2.72 1.51 KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52 Crebbp KLA  ATP  ATP+KLA NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07 ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00 KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13 Crebbp KLA  ATP  ATP+KLA S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08 ATP .99 .98 .99 1.09 1.13 1.08 1.05 KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11 Cul1 KLA  ATP  ATP+KLA NM_012042 cullin 1 (Cul1), mRNA [NM_012042] KLA 1.54 1.57 1.59 1.36 1.13 1.06 1.15 ATP 1.02 1.15 1.00 1.02 1.00 1.16 1.10 KLA/ATP 1.54 1.68 1.30 1.46 .98 1.02 1.12 Dbf4 KLA  ATP  ATP+KLA AK014480 14 days embryo liver cDNA, RIKEN full-length enriched library, clone:4432409B02 product:activator of S phase kinase, full insert sequence. [AK014480] KLA .88 .97 .94 .96 .95 .96 .88 ATP .90 .96 1.03 .92 1.01 .95 .90 KLA/ATP .96 .96 .94 .88 .93 .91 .89 Dbf4 KLA  ATP  ATP+KLA NM_013726 DBF4 homolog (S. cerevisiae) (Dbf4), mRNA [NM_013726] KLA .55 .52 .54 .48 .48 .69 .59 ATP .95 1.02 1.08 1.15 1.52 1.05 .63 KLA/ATP .54 .52 .62 .67 1.10 .94 .45 E2f1 KLA  ATP  ATP+KLA NM_007891 E2F transcription factor 1 (E2f1), mRNA [NM_007891] KLA .41 .44 .42 .41 .48 .77 .90 ATP 1.01 1.09 1.04 1.13 .83 .53 .84 KLA/ATP .44 .44 .52 .50 .49 .46 .85 E2f2 KLA  ATP  ATP+KLA NM_177733 E2F transcription factor 2 (E2f2), mRNA [NM_177733] KLA .13 .13 .14 .20 .19 .19 .18 ATP 1.08 .92 1.01 .85 .65 .38 .38 KLA/ATP .13 .13 .21 .20 .32 .24 .26 E2f3 KLA  ATP  ATP+KLA AK085296 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630007K21 product:E2F transcription factor 3, full insert sequence. [AK085296] KLA .98 .97 1.02 1.00 .99 .99 .99 ATP .97 1.06 1.03 .98 1.01 .99 1.00 KLA/ATP 1.12 1.14 1.03 .99 .96 .93 .96 E2f3 KLA  ATP  ATP+KLA NM_010093 E2F transcription factor 3 (E2f3), mRNA [NM_010093] KLA 1.11 1.09 1.13 1.21 1.47 1.62 1.65 ATP .97 .98 1.08 1.15 1.45 1.73 1.80 KLA/ATP 1.21 1.13 1.07 1.20 1.45 1.56 1.62 E2f4 KLA  ATP  ATP+KLA NM_148952 E2F transcription factor 4 (E2f4), mRNA [NM_148952] KLA 1.12 1.11 1.05 1.36 1.41 1.24 1.32 ATP 1.09 1.10 1.06 1.33 1.15 1.26 1.16 KLA/ATP 1.10 1.21 1.06 1.25 .90 1.12 1.41 E2f5 KLA  ATP  ATP+KLA AK028856 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732463D08 product:unclassifiable, full insert sequence [AK028856] KLA 1.04 1.04 .97 .94 1.02 1.03 1.06 ATP .94 .95 1.05 1.13 1.07 .99 1.04 KLA/ATP 1.01 1.02 .96 1.01 1.04 1.02 1.00 E2f5 KLA  ATP  ATP+KLA NM_007892 E2F transcription factor 5 (E2f5), mRNA [NM_007892] KLA 2.26 2.26 2.58 2.14 1.76 1.32 1.34 ATP .94 1.03 1.08 1.20 1.55 2.09 .79 KLA/ATP 2.20 2.30 2.17 2.85 2.23 2.03 1.50 E2f5 KLA  ATP  ATP+KLA X86925 gb|M.musculus mRNA for E2F-5 protein. [X86925] KLA 2.12 2.10 2.40 2.23 1.81 1.31 1.25 ATP .95 .91 1.19 1.12 1.70 2.41 .77 KLA/ATP 2.23 2.10 2.79 2.62 2.72 2.29 1.55 Ep300 KLA  ATP  ATP+KLA AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05 ATP 1.06 .89 .88 .89 1.00 .90 1.07 KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98 Ep300 KLA  ATP  ATP+KLA NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40 ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15 KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05 Espl1 KLA  ATP  ATP+KLA AK076351 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732457F20 product:unclassifiable, full insert sequence. [AK076351] KLA .97 1.01 .97 1.01 .99 .99 .93 ATP 1.02 1.01 .94 1.04 1.01 .99 .92 KLA/ATP 1.04 .94 .89 1.06 1.00 .93 .93 Espl1 KLA  ATP  ATP+KLA NM_001014976 extra spindle poles-like 1 (S. cerevisiae) (Espl1), mRNA [NM_001014976] KLA .26 .26 .22 .27 .36 .44 .34 ATP 1.06 1.13 .97 .98 .59 .37 .31 KLA/ATP .30 .25 .32 .34 .27 .28 .25 Fzr1 KLA  ATP  ATP+KLA NM_019757 fizzy/cell division cycle 20 related 1 (Drosophila) (Fzr1), mRNA [NM_019757] KLA 1.08 .98 .95 1.03 1.44 1.33 .97 ATP 1.06 1.19 .93 1.16 1.05 1.21 .94 KLA/ATP 1.02 1.05 .83 1.04 .84 1.21 1.43 Gadd45a KLA  ATP  ATP+KLA NM_007836 growth arrest and DNA-damage-inducible 45 alpha (Gadd45a), mRNA [NM_007836] KLA .52 .72 .68 .82 1.11 .73 1.91 ATP .92 .85 1.20 3.38 7.86 3.35 3.64 KLA/ATP .54 .95 1.60 3.49 5.04 3.79 2.80 Gadd45b KLA  ATP  ATP+KLA NM_008655 growth arrest and DNA-damage-inducible 45 beta (Gadd45b), mRNA [NM_008655] KLA 10.08 11.65 8.40 11.27 8.24 7.30 5.74 ATP 1.83 3.28 10.08 27.60 15.97 8.84 4.61 KLA/ATP 9.36 14.99 21.30 45.24 49.27 21.63 22.73 Gadd45g KLA  ATP  ATP+KLA NM_011817 growth arrest and DNA-damage-inducible 45 gamma (Gadd45g), mRNA [NM_011817] KLA 2.18 2.14 2.95 3.62 3.22 4.69 1.21 ATP 1.01 1.74 8.49 11.83 4.60 5.94 5.94 KLA/ATP 2.58 3.99 12.54 13.16 12.25 12.41 12.33 Gsk3b KLA  ATP  ATP+KLA NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26 ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67 KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99 Hdac1 KLA  ATP  ATP+KLA U80780 putative histone deacetylase (HD1) mRNA, partial cds [U80780] KLA 2.59 2.39 2.48 2.74 3.36 2.56 1.22 ATP 1.13 1.26 1.18 1.08 .85 1.29 1.15 KLA/ATP 2.15 2.27 2.64 2.57 1.78 1.89 2.31 Hdac2 KLA  ATP  ATP+KLA AK051753 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130072G11 product:histone deacetylase 2, full insert sequence [AK051753] KLA .97 .97 .90 .96 1.02 .93 .96 ATP 1.02 1.03 .98 .96 .96 .90 1.05 KLA/ATP 1.00 .96 .87 .99 .92 1.00 .95 Hdac2 KLA  ATP  ATP+KLA NM_008229 histone deacetylase 2 (Hdac2), mRNA [NM_008229] KLA 1.27 1.35 1.33 1.18 1.03 .75 1.10 ATP .95 1.05 .79 .96 .82 .85 .81 KLA/ATP 1.28 1.43 .93 1.10 .82 .73 .60 LOC10004 7731 KLA  ATP  ATP+KLA XM_001479148 ref|PREDICTED: Mus musculus hypothetical protein LOC100047731 (LOC100047731), mRNA [XM_001479148] KLA .93 .89 .90 .88 1.06 .98 .84 ATP .86 .74 .85 1.00 1.20 .99 .85 KLA/ATP .85 .78 .79 .84 .92 .88 .73 Mad1l1 KLA  ATP  ATP+KLA NM_010752 mitotic arrest deficient 1-like 1 (Mad1l1), mRNA [NM_010752] KLA .92 .84 .84 .78 .59 .63 .61 ATP .94 .99 1.19 1.39 .78 .52 .72 KLA/ATP .87 .92 .91 .96 .68 .54 .59 Mad2l1 KLA  ATP  ATP+KLA NM_019499 MAD2 (mitotic arrest deficient, homolog)-like 1 (yeast) (Mad2l1), mRNA [NM_019499] KLA .70 .68 .73 .71 .52 .41 .28 ATP 1.06 1.02 1.43 1.25 1.03 .53 .19 KLA/ATP .70 .69 .99 .84 .70 .43 .18 Mad2l1 KLA  ATP  ATP+KLA U83902 mitotic checkpoint component Mad2 mRNA, complete cds. [U83902] KLA .67 .68 .67 .60 .50 .39 .27 ATP .95 .97 1.28 1.28 .88 .54 .19 KLA/ATP .62 .66 .84 .91 .62 .41 .18 Mad2l2 KLA  ATP  ATP+KLA NM_027985 MAD2 mitotic arrest deficient-like 2 (yeast) (Mad2l2), mRNA [NM_027985] KLA 1.47 1.43 1.53 1.81 1.64 1.37 1.24 ATP 1.05 .92 1.13 1.24 1.09 1.00 .85 KLA/ATP 1.47 1.50 1.78 1.50 1.75 1.58 1.05 Mcm2 KLA  ATP  ATP+KLA NM_008564 minichromosome maintenance deficient 2 mitotin (S. cerevisiae) (Mcm2), mRNA [NM_008564] KLA .24 .24 .17 .13 .12 .35 .23 ATP 1.00 1.01 1.06 1.02 .54 .18 .33 KLA/ATP .28 .23 .20 .21 .17 .19 .11 Mcm3 KLA  ATP  ATP+KLA AK088142 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430004P22 product:mini chromosome maintenance deficient (S. cerevisiae), full insert sequence [AK088142] KLA .33 .29 .27 .22 .20 .37 .31 ATP .88 .90 1.19 1.06 .67 .29 .30 KLA/ATP .30 .28 .33 .30 .25 .22 .13 Mcm3 KLA  ATP  ATP+KLA NM_008563 minichromosome maintenance deficient 3 (S. cerevisiae) (Mcm3), mRNA [NM_008563] KLA .37 .36 .32 .24 .22 .38 .34 ATP 1.01 1.07 1.03 1.17 .75 .30 .32 KLA/ATP .36 .35 .35 .37 .27 .21 .15 Mcm4 KLA  ATP  ATP+KLA AK083618 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030054K02 product:mini chromosome maintenance deficient 4 homolog (S. cerevisiae), full insert sequence. [AK083618] KLA .94 .94 .95 .94 .98 .95 .94 ATP .93 .91 .92 .93 1.06 .93 1.02 KLA/ATP .95 .95 .95 .91 .93 .95 .95 Mcm4 KLA  ATP  ATP+KLA NM_008565 minichromosome maintenance deficient 4 homolog (S. cerevisiae) (Mcm4), mRNA [NM_008565] KLA .37 .37 .29 .20 .18 .37 .25 ATP .95 .97 1.11 .88 .67 .31 .28 KLA/ATP .36 .33 .35 .27 .25 .32 .14 Mcm5 KLA  ATP  ATP+KLA NM_008566 minichromosome maintenance deficient 5, cell division cycle 46 (S. cerevisiae) (Mcm5), mRNA [NM_008566] KLA .48 .49 .44 .34 .28 .34 .30 ATP 1.04 1.09 .86 1.11 .67 .32 .29 KLA/ATP .52 .50 .37 .50 .35 .28 .23 Mcm6 KLA  ATP  ATP+KLA NM_008567 minichromosome maintenance deficient 6 (MIS5 homolog, S. pombe) (S. cerevisiae) (Mcm6), mRNA [NM_008567] KLA .59 .54 .53 .54 .37 .45 .24 ATP .99 .89 1.17 .80 .58 .16 .23 KLA/ATP .51 .53 .65 .43 .41 .17 .08 Mcm7 KLA  ATP  ATP+KLA NM_008568 minichromosome maintenance deficient 7 (S. cerevisiae) (Mcm7), mRNA [NM_008568] KLA .31 .31 .25 .16 .12 .21 .14 ATP 1.08 1.10 1.01 1.01 .59 .21 .16 KLA/ATP .36 .29 .26 .26 .18 .16 .09 Mdm2 KLA  ATP  ATP+KLA NM_010786 transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA [NM_010786] KLA 1.77 1.59 1.98 1.51 1.77 1.60 1.77 ATP 1.01 1.21 1.36 3.24 5.04 2.08 1.36 KLA/ATP 1.89 1.86 2.93 5.65 5.98 2.78 2.64 Mm.18219 3 KLA  ATP  ATP+KLA 142389041 Unknown KLA 1.02 .95 .88 .77 .57 .48 .37 ATP .90 .88 .99 1.10 1.08 .77 .36 KLA/ATP .92 .88 1.01 1.04 1.17 .79 .32 Mm.1904 KLA  ATP  ATP+KLA 159110850 Unknown KLA .72 .72 .83 .76 .72 .68 .69 ATP 1.04 1.00 1.09 .96 .78 .78 .54 KLA/ATP .75 .74 .89 .81 .74 .67 .55 Mm.27304 9 KLA  ATP  ATP+KLA 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16 ATP 1.08 1.05 .88 .78 .47 .09 .20 KLA/ATP .28 .22 .21 .24 .26 .22 .12 Mm.30793 2 KLA  ATP  ATP+KLA 160333363 Unknown KLA .13 .12 .14 .16 .15 .18 .15 ATP .92 .94 1.12 .93 .58 .29 .31 KLA/ATP .11 .11 .18 .20 .28 .20 .19 Mm.35584 KLA  ATP  ATP+KLA 70909358 Unknown KLA .22 .25 .28 .33 .40 .77 .46 ATP 1.05 .96 1.08 .56 1.10 .79 .74 KLA/ATP .23 .25 .32 .25 .90 1.02 .60 Mm.47351 0 KLA  ATP  ATP+KLA 162287332 Unknown KLA 4.46 4.82 5.29 4.00 2.26 1.25 1.10 ATP 1.24 1.72 1.02 2.08 1.66 2.53 .55 KLA/ATP 6.11 7.67 4.29 6.99 3.11 2.86 2.30 Mm.71 KLA  ATP  ATP+KLA 124517705 Unknown KLA .65 .58 .48 .42 .35 .47 .60 ATP .96 .95 1.22 1.00 .55 .33 .76 KLA/ATP .62 .60 .66 .43 .36 .31 .45 Myc KLA  ATP  ATP+KLA NM_010849 myelocytomatosis oncogene (Myc), mRNA [NM_010849] KLA .38 .31 .45 .45 .49 .35 .33 ATP 1.05 1.09 1.72 4.41 1.28 .45 .76 KLA/ATP .37 .30 .44 1.23 .34 .17 .19 Orc1l KLA  ATP  ATP+KLA NM_011015 origin recognition complex, subunit 1-like (S.cereviaiae) (Orc1l), transcript variant A, mRNA [NM_011015] KLA .66 .65 .61 .53 .53 .69 .49 ATP .96 .97 1.04 .99 1.12 .68 .49 KLA/ATP .65 .64 .67 .65 .87 .87 .42 Orc2l KLA  ATP  ATP+KLA NM_008765 origin recognition complex, subunit 2-like (S. cerevisiae) (Orc2l), transcript variant a, mRNA [NM_008765] KLA .69 .64 .67 .64 .61 .75 .78 ATP .97 .91 1.01 .77 .82 .76 .72 KLA/ATP .74 .69 .83 .59 .60 .61 .37 Orc3l KLA  ATP  ATP+KLA AK140926 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130072M21 product:unclassifiable, full insert sequence [AK140926] KLA .81 .75 .75 .81 .86 .82 .72 ATP 1.04 .97 1.02 .81 1.08 .83 .55 KLA/ATP .73 .71 .72 .77 1.27 .82 .60 Orc3l KLA  ATP  ATP+KLA NM_015824 origin recognition complex, subunit 3-like (S. cerevisiae) (Orc3l), mRNA [NM_015824] KLA .98 .99 1.03 1.07 1.12 1.05 1.09 ATP 1.07 1.06 1.08 1.00 .73 .69 .95 KLA/ATP 1.03 1.07 1.04 .98 .76 .61 .84 Orc4l KLA  ATP  ATP+KLA AK049534 7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430020D18 product:origin recognition complex, subunit 4, full insert sequence. [AK049534] KLA 1.01 1.04 1.01 1.05 .95 .96 1.13 ATP 1.01 1.04 .98 .92 .90 .96 1.16 KLA/ATP 1.09 .96 1.00 .97 .94 .95 .94 Orc4l KLA  ATP  ATP+KLA NM_011958 origin recognition complex, subunit 4-like (S. cerevisiae) (Orc4l), mRNA [NM_011958] KLA 1.76 1.62 1.67 1.64 1.35 1.47 1.32 ATP .89 .94 1.22 1.06 1.08 1.10 1.06 KLA/ATP 1.42 1.52 1.85 1.50 1.36 1.22 1.16 Orc5l KLA  ATP  ATP+KLA AK054452 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330027E23 product:unclassifiable, full insert sequence [AK054452] KLA 1.02 1.02 .90 1.04 1.02 1.02 .98 ATP 1.04 1.02 .97 .99 .95 1.05 1.06 KLA/ATP 1.02 1.00 1.00 1.04 1.00 .95 1.03 Orc5l KLA  ATP  ATP+KLA NM_011959 origin recognition complex, subunit 5-like (S. cerevisiae) (Orc5l), mRNA [NM_011959] KLA .78 .78 .72 .87 .92 .94 1.15 ATP 1.27 1.53 .95 1.07 .38 .58 1.37 KLA/ATP .78 .94 .62 .91 .40 .47 .97 Orc6l KLA  ATP  ATP+KLA NM_019716 origin recognition complex, subunit 6-like (S. cerevisiae) (Orc6l), mRNA [NM_019716] KLA .48 .36 .37 .41 .41 .53 .39 ATP .97 .94 1.06 .74 .79 .65 .48 KLA/ATP .39 .34 .51 .39 .52 .65 .38 Pcna KLA  ATP  ATP+KLA NM_011045 proliferating cell nuclear antigen (Pcna), mRNA [NM_011045] KLA .70 .69 .73 .56 .46 .66 .55 ATP .98 .95 1.12 .81 .74 .49 .92 KLA/ATP .69 .66 .78 .60 .63 .59 .62 Plk1 KLA  ATP  ATP+KLA NM_011121 polo-like kinase 1 (Drosophila) (Plk1), mRNA [NM_011121] KLA .28 .23 .26 .20 .16 .13 .08 ATP 1.09 1.06 1.15 1.07 .71 .53 .10 KLA/ATP .42 .26 .29 .29 .32 .25 .12 Prkdc KLA  ATP  ATP+KLA NM_011159 protein kinase, DNA activated, catalytic polypeptide (Prkdc), mRNA [NM_011159] KLA .69 .67 .58 .52 .47 .54 .73 ATP 1.12 1.12 1.09 1.05 .60 .42 .83 KLA/ATP .74 .71 .65 .57 .45 .41 .55 Pttg1 KLA  ATP  ATP+KLA NM_013917 pituitary tumor-transforming 1 (Pttg1), mRNA [NM_013917] KLA 3.06 2.73 3.51 4.09 3.52 2.99 2.09 ATP 1.06 .94 1.23 1.15 1.33 2.08 1.43 KLA/ATP 3.07 2.93 4.25 3.27 4.24 4.01 3.35 Rad21 KLA  ATP  ATP+KLA NM_009009 RAD21 homolog (S. pombe) (Rad21), mRNA [NM_009009] KLA .86 .88 .92 .75 .67 .68 .56 ATP .98 1.11 1.09 1.07 .88 .83 .47 KLA/ATP .84 .92 .78 .89 .79 .90 .66 Rb1 KLA  ATP  ATP+KLA NM_009029 retinoblastoma 1 (Rb1), mRNA [NM_009029] KLA .67 .60 .55 .51 .46 .75 .79 ATP 1.04 1.01 1.12 .86 .59 .43 .76 KLA/ATP .64 .59 .58 .46 .36 .30 .65 Rbl1 KLA  ATP  ATP+KLA NM_011249 retinoblastoma-like 1 (p107) (Rbl1), mRNA [NM_011249] KLA 3.37 3.24 4.88 3.79 2.52 1.65 .61 ATP 1.08 1.11 1.29 .91 .48 .56 .53 KLA/ATP 3.36 3.65 4.38 3.36 2.12 1.71 1.31 Rbl2 KLA  ATP  ATP+KLA NM_011250 retinoblastoma-like 2 (Rbl2), mRNA [NM_011250] KLA .66 .69 .65 .51 .55 .57 .78 ATP 1.11 1.32 .95 1.14 .57 .47 .65 KLA/ATP .77 .76 .52 .64 .41 .52 .59 Rbx1 KLA  ATP  ATP+KLA NM_019712 ring-box 1 (Rbx1), mRNA [NM_019712] KLA 1.04 1.01 .98 1.09 1.06 1.14 1.09 ATP .92 .89 1.13 1.16 1.68 1.07 .83 KLA/ATP .99 .99 1.25 1.31 2.63 2.06 .67 Sfn KLA  ATP  ATP+KLA AF058798 14-3-3 protein sigma mRNA, complete cds. [AF058798] KLA 1.07 1.11 1.08 .99 .94 .97 1.05 ATP 1.06 1.05 1.04 1.29 3.02 3.37 1.05 KLA/ATP 1.13 1.13 1.06 1.17 2.83 3.94 2.23 Sfn KLA  ATP  ATP+KLA NM_018754 stratifin (Sfn), mRNA [NM_018754] KLA .97 1.07 1.09 .99 .96 .97 1.02 ATP 1.03 1.08 1.07 1.33 1.98 2.15 .90 KLA/ATP 1.10 1.02 .97 1.23 1.99 2.58 1.39 Skp1a KLA  ATP  ATP+KLA NM_011543 S-phase kinase-associated protein 1A (Skp1a), mRNA [NM_011543] KLA 1.05 1.00 .92 .92 .88 .89 1.02 ATP .90 .98 1.21 1.43 1.32 1.46 1.09 KLA/ATP .93 1.01 1.11 1.31 1.21 1.27 1.21 Skp2 KLA  ATP  ATP+KLA AF083215 SCF complex protein Skp2 mRNA, complete cds. [AF083215] KLA .36 .37 .34 .37 .44 .78 .60 ATP 1.05 1.35 .85 .66 .83 .54 .76 KLA/ATP .33 .39 .37 .37 .65 .73 .62 Smad2 KLA  ATP  ATP+KLA NM_010754 MAD homolog 2 (Drosophila) (Smad2), mRNA [NM_010754] KLA 1.05 1.08 1.04 1.17 1.40 1.43 1.59 ATP 1.01 1.02 1.16 1.14 1.15 1.32 1.34 KLA/ATP 1.00 .99 .97 1.09 1.40 1.14 1.40 Smad3 KLA  ATP  ATP+KLA NM_016769 MAD homolog 3 (Drosophila) (Smad3), mRNA [NM_016769] KLA .64 .60 .57 .64 .70 1.25 1.52 ATP 1.02 1.02 .84 1.21 2.42 .90 1.19 KLA/ATP .64 .60 .65 .66 1.29 1.26 2.26 Smad4 KLA  ATP  ATP+KLA NM_008540 MAD homolog 4 (Drosophila) (Smad4), mRNA [NM_008540] KLA 1.11 1.11 1.13 1.09 1.02 .98 1.08 ATP 1.00 1.04 .92 .76 1.67 1.44 .92 KLA/ATP 1.09 1.01 .87 .89 1.64 1.43 .99 Smc1a KLA  ATP  ATP+KLA NM_019710 structural maintenance of chromosomes 1A (Smc1a), mRNA [NM_019710] KLA .89 .97 .93 .86 .82 .82 .73 ATP 1.08 1.20 1.07 1.17 1.00 .77 .62 KLA/ATP 1.00 1.01 .88 1.00 .82 .70 .61 Smc1b KLA  ATP  ATP+KLA NM_080470 structural maintenace of chromosomes 1B (Smc1b), mRNA [NM_080470] KLA 1.17 1.08 1.19 1.25 1.37 1.41 1.75 ATP 1.01 1.02 1.01 1.03 .92 1.00 1.23 KLA/ATP 1.06 1.13 1.08 1.07 1.02 1.07 1.59 Smc3 KLA  ATP  ATP+KLA NM_007790 structural maintenace of chromosomes 3 (Smc3), mRNA [NM_007790] KLA .55 .54 .58 .53 .55 .60 .56 ATP 1.00 1.10 1.01 .96 .88 .65 .56 KLA/ATP .53 .57 .59 .59 .65 .57 .45 Stag1 KLA  ATP  ATP+KLA NM_009282 stromal antigen 1 (Stag1), mRNA [NM_009282] KLA 1.41 1.46 1.66 1.52 1.12 .94 .95 ATP 1.03 1.07 1.02 1.09 .66 .81 .74 KLA/ATP 1.48 1.56 1.50 1.51 .84 .82 .74 Stag2 KLA  ATP  ATP+KLA AK077318 adult male pituitary gland cDNA, RIKEN full-length enriched library, clone:5330413G05 product:stromal antigen 2, full insert sequence. [AK077318] KLA 1.63 1.57 1.42 1.20 1.42 1.12 1.07 ATP 1.36 1.26 1.24 .95 1.34 1.19 1.02 KLA/ATP 1.94 1.89 1.71 1.28 1.39 1.09 .98 Stag2 KLA  ATP  ATP+KLA NM_001077712 stromal antigen 2 (Stag2), transcript variant 2, mRNA [NM_001077712] KLA 2.73 2.77 2.75 2.43 1.81 1.18 .90 ATP 1.10 1.18 .78 .76 .65 1.01 .94 KLA/ATP 2.66 2.60 2.02 1.57 .94 1.11 1.43 Tfdp1 KLA  ATP  ATP+KLA BC058633 transcription factor Dp 1, mRNA (cDNA clone IMAGE:6416171), partial cds [BC058633] KLA .71 .75 .68 .62 .52 .54 .51 ATP .99 1.09 .94 .96 .68 .60 .53 KLA/ATP .76 .75 .58 .61 .45 .57 .36 Tfdp1 KLA  ATP  ATP+KLA NM_009361 transcription factor Dp 1 (Tfdp1), mRNA [NM_009361] KLA .70 .71 .65 .55 .48 .52 .50 ATP .97 1.14 .94 1.00 .65 .53 .51 KLA/ATP .66 .71 .52 .55 .38 .48 .33 Tfdp2 KLA  ATP  ATP+KLA NM_178667 transcription factor Dp 2 (Tfdp2), mRNA [NM_178667] KLA .69 .77 .72 .71 .60 .62 .62 ATP 1.03 1.03 1.06 1.10 .79 .71 .73 KLA/ATP .76 .73 .70 .80 .68 .68 .57 Tfdp2 KLA  ATP  ATP+KLA S79780 gb|DP-3=protein regulating cell cycle transcription factor DRTF1/E2F [mice, pl-2, F9 EC, mRNA, 1380 nt]. [S79780] KLA .52 .58 .49 .57 .54 .50 .41 ATP .95 1.06 .95 .82 .73 .55 .41 KLA/ATP .51 .53 .58 .60 .60 .60 .35 Tgfb1 KLA  ATP  ATP+KLA NM_011577 transforming growth factor, beta 1 (Tgfb1), mRNA [NM_011577] KLA .87 .89 .90 .70 .83 .77 1.12 ATP 1.20 1.41 .80 1.49 1.11 .93 .99 KLA/ATP 1.10 1.20 .53 1.05 .66 .85 .90 Tgfb2 KLA  ATP  ATP+KLA NM_009367 transforming growth factor, beta 2 (Tgfb2), mRNA [NM_009367] KLA 1.01 .91 .98 .98 .92 1.19 .96 ATP .99 1.03 1.00 1.02 .99 1.07 .93 KLA/ATP 1.02 .99 1.03 .98 1.04 1.06 .96 Tgfb3 KLA  ATP  ATP+KLA NM_009368 transforming growth factor, beta 3 (Tgfb3), mRNA [NM_009368] KLA .67 .64 .58 .56 .49 .52 .61 ATP .90 .92 1.33 1.08 .78 .65 .74 KLA/ATP .58 .60 .74 .61 .76 1.36 1.51 Trp53 KLA  ATP  ATP+KLA NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95 ATP 1.15 1.32 .90 1.85 1.26 .68 .70 KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74 Ttk KLA  ATP  ATP+KLA NM_009445 Ttk protein kinase (Ttk), transcript variant 1, mRNA [NM_009445] KLA .63 .65 .67 .68 .58 .61 .38 ATP 1.02 1.12 1.02 .91 .66 .65 .34 KLA/ATP .62 .66 .67 .76 .68 .62 .35 Wee1 KLA  ATP  ATP+KLA NM_009516 wee 1 homolog (S. pombe) (Wee1), mRNA [NM_009516] KLA .82 .81 .83 .62 .51 .64 .47 ATP 1.04 1.15 .89 1.06 1.04 .63 .64 KLA/ATP .80 .90 .76 .72 .77 .77 .46 Wee2 KLA  ATP  ATP+KLA NM_201370 WEE1 homolog 2 (S. pombe) (Wee2), mRNA [NM_201370] KLA 1.00 1.03 1.12 1.03 .98 1.02 .93 ATP 1.02 1.02 1.04 1.07 1.06 1.05 .97 KLA/ATP 1.11 1.09 1.03 1.04 .99 .94 1.02 Ywhab KLA  ATP  ATP+KLA NM_018753 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (Ywhab), mRNA [NM_018753] KLA 1.03 1.15 1.18 1.10 1.20 1.20 1.23 ATP 1.02 1.08 .84 1.06 1.08 1.24 1.24 KLA/ATP 1.15 1.18 .82 1.17 .91 1.24 1.58 Ywhae KLA  ATP  ATP+KLA NM_009536 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (Ywhae), mRNA [NM_009536] KLA 1.32 1.35 1.43 1.40 1.46 1.45 1.19 ATP 1.09 1.30 1.21 1.51 1.16 .97 1.01 KLA/ATP 1.45 1.50 1.33 1.85 1.25 1.16 1.08 Ywhag KLA  ATP  ATP+KLA NM_018871 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (Ywhag), mRNA [NM_018871] KLA .87 .96 .92 .89 1.14 1.30 1.77 ATP 1.08 1.22 .86 .83 .91 1.46 1.09 KLA/ATP 1.05 1.04 .61 .72 .76 1.44 1.52 Ywhah KLA  ATP  ATP+KLA NM_011738 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide (Ywhah), mRNA [NM_011738] KLA .55 .54 .49 .44 .38 .58 .70 ATP .99 .93 1.14 .81 .62 .53 1.07 KLA/ATP .54 .52 .54 .35 .37 .35 .68 Ywhaq KLA  ATP  ATP+KLA AK037746 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130046D12 product:unclassifiable, full insert sequence [AK037746] KLA .97 .93 .94 .95 .97 .96 .95 ATP 1.09 1.07 1.44 1.49 1.04 1.01 .96 KLA/ATP 1.04 .96 1.11 1.36 1.01 1.03 .87 Ywhaq KLA  ATP  ATP+KLA NM_011739 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (Ywhaq), mRNA [NM_011739] KLA .93 .98 .96 .99 .92 .76 .88 ATP 1.07 1.08 1.01 1.35 1.37 1.28 .70 KLA/ATP .97 1.04 .94 1.17 1.09 1.18 .77 Ywhaz KLA  ATP  ATP+KLA AK050511 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820005J08 product:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, full insert sequence. [AK050511] KLA .99 .96 .97 .96 1.00 .95 .96 ATP .99 1.00 .98 1.01 1.04 .94 1.01 KLA/ATP .99 .97 1.00 .98 .88 .97 1.01 Ywhaz KLA  ATP  ATP+KLA NM_011740 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), mRNA [NM_011740] KLA 1.79 1.86 1.98 2.10 2.11 2.10 1.30 ATP 1.00 1.21 .95 1.37 1.21 1.42 1.08 KLA/ATP 1.73 1.92 1.58 2.28 1.68 1.76 1.47 Zbtb17 KLA  ATP  ATP+KLA NM_009541 zinc finger and BTB domain containing 17 (Zbtb17), mRNA [NM_009541] KLA .78 .82 .90 .76 .87 .84 1.04 ATP 1.01 1.05 .94 1.58 2.04 1.29 1.21 KLA/ATP .86 .81 .77 .96 1.44 1.28 1.44